Merck reports surging sales of vaccines and key cancer drug - Washington Post
Merck reports surging sales of vaccines and key cancer drug Washington Post
Merck breezed past almost all expectations for the first quarter with global sales jumping 8 percent to almost $11 billion.
Comments
Post a Comment